PRECIPIO, INC. Accrued Liabilities, Current
PRECIPIO, INC. (PRPO) had Accrued Liabilities, Current of $1.64 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $1.64M.
- 2026-03-31: Accrued Liabilities, Current $1.66M.
- 2025-12-31: Accrued Liabilities, Current $1.69M.
- 2025-09-30: Accrued Liabilities, Current $2.43M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.64M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.66M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.69M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.43M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.48M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.66M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.80M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.74M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $2.92M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.82M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.82M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.21M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.90M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $1.69M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.58M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $1.54M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.43M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.67M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.92M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.56M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.34M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.76M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.04M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $1.80M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.95M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.83M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.64M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.66M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.65M 10-Q · filed 2019-05-16 | |
| 2018-12-31 | $1.94M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $1.82M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $1.14M 10-Q · filed 2018-08-16 | |
| 2018-03-31 | $1.53M 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $1.25M 10-K · filed 2019-04-16 | |
| 2017-09-30 | $1.87M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $3.52M 10-Q · filed 2017-08-22 | |
| 2017-03-31 | $3.40M 10-Q · filed 2017-05-18 | |
| 2016-12-31 | $700.00K 10-K · filed 2018-04-13 | $3.55M 10-K · filed 2017-04-13 |
| 2016-09-30 | $2.70M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.85M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.34M 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $3.73M 10-K · filed 2017-04-13 | |
| 2015-09-30 | $2.37M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $2.70M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $2.37M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $2.04M 10-K · filed 2016-04-14 | $2.55M 10-K · filed 2015-04-15 |
| 2014-09-30 | $1.96M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $2.04M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.81M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $2.04M 10-K · filed 2015-04-15 | |
| 2013-09-30 | $2.39M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $2.29M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $2.83M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $3.69M 10-K · filed 2014-03-27 | |
| 2012-09-30 | $3.63M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $3.88M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $3.59M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $2.78M 10-K · filed 2013-03-14 | $3.84M 10-K · filed 2012-03-14 |
| 2011-09-30 | $3.83M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $3.68M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $3.23M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |